GRI
GRI Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.93
+4.89%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-116.3%
Return on equity
-105.1%
Return on assets
-116.0%
Return on invested capital
0.00x
Asset turnover
-$10.2M
Cash from operations
$5.01
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026